Do analysts rate TELA or MBAI?

TELA Bio presently has a consensus target price of $2.20, indicating a potential upside of 181.69%. Given TELA Bio's stronger consensus rating and higher probable upside, analysts plainly believe TELA Bio is more favorable than Check-Cap. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TELA Bio 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Check-Cap 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is TELA or MBAI more profitable?

Check-Cap has a net margin of 0.00% compared to TELA Bio's net margin of -51.53%. Check-Cap's return on equity of 0.00% beat TELA Bio's return on equity. Company Net Margins Return on Equity Return on Assets TELA Bio -51.53% -1,320.81% -59.39% Check-Cap N/A N/A N/A

Does the media favor TELA or MBAI?

In the previous week, TELA Bio had 1 more articles in the media than Check-Cap. MarketBeat recorded 4 mentions for TELA Bio and 3 mentions for Check-Cap. Check-Cap's average media sentiment score of 0.00 beat TELA Bio's score of -0.28 indicating that Check-Cap is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TELA Bio 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Check-Cap 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate ARAY or MBAI?

Accuray currently has a consensus price target of $2.00, suggesting a potential upside of 651.88%. Given Accuray's stronger consensus rating and higher probable upside, equities analysts plainly believe Accuray is more favorable than Check-Cap. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Accuray 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67 Check-Cap 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is ARAY or MBAI more profitable?

Check-Cap has a net margin of 0.00% compared to Accuray's net margin of -12.24%. Check-Cap's return on equity of 0.00% beat Accuray's return on equity. Company Net Margins Return on Equity Return on Assets Accuray -12.24% -97.85% -10.82% Check-Cap N/A N/A N/A

Does the media refer more to ARAY or MBAI?

In the previous week, Check-Cap had 2 more articles in the media than Accuray. MarketBeat recorded 3 mentions for Check-Cap and 1 mentions for Accuray. Accuray's average media sentiment score of 0.68 beat Check-Cap's score of 0.00 indicating that Accuray is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Accuray 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Check-Cap 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer QTEX or MBAI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Check-Cap 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings & valuation, QTEX or MBAI?

Check-Cap has lower revenue, but higher earnings than Inspira Technologies OXY B.H.N.. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Inspira Technologies OXY B.H.N. $290K 101.45 -$13.22M N/A N/A Check-Cap N/A N/A $4.14M -$14.07 N/A

Is QTEX or MBAI more profitable?

Company Net Margins Return on Equity Return on Assets Inspira Technologies OXY B.H.N. N/A N/A N/A Check-Cap N/A N/A N/A

Does the media favor QTEX or MBAI?

In the previous week, Inspira Technologies OXY B.H.N. had 1 more articles in the media than Check-Cap. MarketBeat recorded 4 mentions for Inspira Technologies OXY B.H.N. and 3 mentions for Check-Cap. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.00 equaled Check-Cap'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inspira Technologies OXY B.H.N. 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Check-Cap 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer MBAI or IINN?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Check-Cap 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, MBAI or IINN?

Check-Cap has higher earnings, but lower revenue than Inspira Technologies OXY B.H.N.. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Check-Cap N/A N/A $4.14M -$14.07 N/A Inspira Technologies OXY B.H.N. $289K 101.55 -$13.22M N/A N/A

Is MBAI or IINN more profitable?

Company Net Margins Return on Equity Return on Assets Check-Cap N/A N/A N/A Inspira Technologies OXY B.H.N. N/A N/A N/A

Does the media prefer MBAI or IINN?

In the previous week, Check-Cap had 1 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 3 mentions for Check-Cap and 2 mentions for Inspira Technologies OXY B.H.N.. Check-Cap's average media sentiment score of 0.00 equaled Inspira Technologies OXY B.H.N.'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Check-Cap 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Inspira Technologies OXY B.H.N. 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer MBAI or MODD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Check-Cap 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Modular Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, MBAI or MODD?

Check-Cap is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Check-Cap N/A N/A $4.14M -$14.07 N/A Modular Medical N/A N/A -$28.24M -$8.69 N/A

Is MBAI or MODD more profitable?

Check-Cap's return on equity of 0.00% beat Modular Medical's return on equity. Company Net Margins Return on Equity Return on Assets Check-Cap N/A N/A N/A Modular Medical N/A -292.14% -222.79%

Does the media refer more to MBAI or MODD?

In the previous week, Modular Medical had 1 more articles in the media than Check-Cap. MarketBeat recorded 4 mentions for Modular Medical and 3 mentions for Check-Cap. Modular Medical's average media sentiment score of 0.20 beat Check-Cap's score of 0.00 indicating that Modular Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Check-Cap 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Modular Medical 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Check-Cap (MBAI) Competitors

$6.50 +0.02 (+0.31%)

As of 09/3/2026 04:00 PM Eastern

Compare

MBAI vs. TELA, ARAY, QTEX, IINN, and MODD

Should you buy Check-Cap stock or one of its competitors? Check-Cap's main competitors and comparable companies include TELA Bio (TELA), Accuray (ARAY), Inspira Technologies OXY B.H.N. (QTEX), Inspira Technologies OXY B.H.N. (IINN), and Modular Medical (MODD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Check-Cap compare to TELA Bio?

TELA Bio (NASDAQ:TELA) and Check-Cap (NASDAQ:MBAI) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation.

TELA Bio has a beta of 1.36, meaning that its share price is 36% more volatile than the broader market. Comparatively, Check-Cap has a beta of 0.67, meaning that its share price is 33% less volatile than the broader market.

94.4% of TELA Bio shares are owned by institutional investors. Comparatively, 1.1% of Check-Cap shares are owned by institutional investors. 5.1% of TELA Bio shares are owned by company insiders. Comparatively, 0.5% of Check-Cap shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Check-Cap has a net margin of 0.00% compared to TELA Bio's net margin of -51.53%. Check-Cap's return on equity of 0.00% beat TELA Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TELA Bio	-51.53%	-1,320.81%	-59.39%
Check-Cap	N/A	N/A	N/A

TELA Bio presently has a consensus target price of $2.20, indicating a potential upside of 181.69%. Given TELA Bio's stronger consensus rating and higher probable upside, analysts plainly believe TELA Bio is more favorable than Check-Cap.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TELA Bio	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Check-Cap	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Check-Cap has lower revenue, but higher earnings than TELA Bio. TELA Bio is trading at a lower price-to-earnings ratio than Check-Cap, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TELA Bio	$80.28M	0.44	-$38.83M	-$0.77	N/A
Check-Cap	N/A	N/A	$4.14M	-$14.07	N/A

In the previous week, TELA Bio had 1 more articles in the media than Check-Cap. MarketBeat recorded 4 mentions for TELA Bio and 3 mentions for Check-Cap. Check-Cap's average media sentiment score of 0.00 beat TELA Bio's score of -0.28 indicating that Check-Cap is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TELA Bio	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
Check-Cap	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

TELA Bio beats Check-Cap on 9 of the 15 factors compared between the two stocks.

How does Check-Cap compare to Accuray?

Accuray (NASDAQ:ARAY) and Check-Cap (NASDAQ:MBAI) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk.

Accuray currently has a consensus price target of $2.00, suggesting a potential upside of 651.88%. Given Accuray's stronger consensus rating and higher probable upside, equities analysts plainly believe Accuray is more favorable than Check-Cap.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Accuray	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Check-Cap	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Check-Cap has a net margin of 0.00% compared to Accuray's net margin of -12.24%. Check-Cap's return on equity of 0.00% beat Accuray's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Accuray	-12.24%	-97.85%	-10.82%
Check-Cap	N/A	N/A	N/A

Accuray has a beta of 1.39, meaning that its stock price is 39% more volatile than the broader market. Comparatively, Check-Cap has a beta of 0.67, meaning that its stock price is 33% less volatile than the broader market.

In the previous week, Check-Cap had 2 more articles in the media than Accuray. MarketBeat recorded 3 mentions for Check-Cap and 1 mentions for Accuray. Accuray's average media sentiment score of 0.68 beat Check-Cap's score of 0.00 indicating that Accuray is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Accuray	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Check-Cap	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

64.1% of Accuray shares are held by institutional investors. Comparatively, 1.1% of Check-Cap shares are held by institutional investors. 2.4% of Accuray shares are held by company insiders. Comparatively, 0.5% of Check-Cap shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Check-Cap has lower revenue, but higher earnings than Accuray. Accuray is trading at a lower price-to-earnings ratio than Check-Cap, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Accuray	$401.95M	0.08	-$49.19M	-$0.40	N/A
Check-Cap	N/A	N/A	$4.14M	-$14.07	N/A

Summary

Accuray beats Check-Cap on 8 of the 14 factors compared between the two stocks.

How does Check-Cap compare to Inspira Technologies OXY B.H.N.?

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) and Check-Cap (NASDAQ:MBAI) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability.

Inspira Technologies OXY B.H.N. has a beta of 4.24, indicating that its share price is 324% more volatile than the broader market. Comparatively, Check-Cap has a beta of 0.67, indicating that its share price is 33% less volatile than the broader market.

Check-Cap has lower revenue, but higher earnings than Inspira Technologies OXY B.H.N..

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspira Technologies OXY B.H.N.	$290K	101.45	-$13.22M	N/A	N/A
Check-Cap	N/A	N/A	$4.14M	-$14.07	N/A

Company	Net Margins	Return on Equity	Return on Assets
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A
Check-Cap	N/A	N/A	N/A

In the previous week, Inspira Technologies OXY B.H.N. had 1 more articles in the media than Check-Cap. MarketBeat recorded 4 mentions for Inspira Technologies OXY B.H.N. and 3 mentions for Check-Cap. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.00 equaled Check-Cap'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inspira Technologies OXY B.H.N.	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Check-Cap	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. Comparatively, 1.1% of Check-Cap shares are held by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are held by insiders. Comparatively, 0.5% of Check-Cap shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Check-Cap	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Inspira Technologies OXY B.H.N. beats Check-Cap on 5 of the 6 factors compared between the two stocks.

How does Check-Cap compare to Inspira Technologies OXY B.H.N.?

Check-Cap (NASDAQ:MBAI) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, media sentiment, profitability, institutional ownership and risk.

Company	Net Margins	Return on Equity	Return on Assets
Check-Cap	N/A	N/A	N/A
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A

In the previous week, Check-Cap had 1 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 3 mentions for Check-Cap and 2 mentions for Inspira Technologies OXY B.H.N.. Check-Cap's average media sentiment score of 0.00 equaled Inspira Technologies OXY B.H.N.'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Check-Cap	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Inspira Technologies OXY B.H.N.	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Check-Cap has higher earnings, but lower revenue than Inspira Technologies OXY B.H.N..

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Check-Cap	N/A	N/A	$4.14M	-$14.07	N/A
Inspira Technologies OXY B.H.N.	$289K	101.55	-$13.22M	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Check-Cap	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

1.1% of Check-Cap shares are held by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. 0.5% of Check-Cap shares are held by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Check-Cap has a beta of 0.67, meaning that its share price is 33% less volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.16, meaning that its share price is 116% more volatile than the broader market.

Summary

Inspira Technologies OXY B.H.N. beats Check-Cap on 4 of the 6 factors compared between the two stocks.

How does Check-Cap compare to Modular Medical?

Check-Cap (NASDAQ:MBAI) and Modular Medical (NASDAQ:MODD) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, profitability, dividends, valuation and analyst recommendations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Check-Cap	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Modular Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Check-Cap has a beta of 0.67, indicating that its share price is 33% less volatile than the broader market. Comparatively, Modular Medical has a beta of 0.45, indicating that its share price is 55% less volatile than the broader market.

1.1% of Check-Cap shares are owned by institutional investors. Comparatively, 27.5% of Modular Medical shares are owned by institutional investors. 0.5% of Check-Cap shares are owned by company insiders. Comparatively, 7.1% of Modular Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Check-Cap is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Check-Cap	N/A	N/A	$4.14M	-$14.07	N/A
Modular Medical	N/A	N/A	-$28.24M	-$8.69	N/A

Check-Cap's return on equity of 0.00% beat Modular Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Check-Cap	N/A	N/A	N/A
Modular Medical	N/A	-292.14%	-222.79%

In the previous week, Modular Medical had 1 more articles in the media than Check-Cap. MarketBeat recorded 4 mentions for Modular Medical and 3 mentions for Check-Cap. Modular Medical's average media sentiment score of 0.20 beat Check-Cap's score of 0.00 indicating that Modular Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Check-Cap	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Modular Medical	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Modular Medical beats Check-Cap on 6 of the 10 factors compared between the two stocks.

Get Check-Cap News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MBAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MBAI vs. The Competition

Export

Metric	Check-Cap	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$8.91M	$5.81B	$7.26B	$12.73B
Dividend Yield	N/A	1.76%	2.53%	8.86%
P/E Ratio	-0.46	25.93	273.28	25.38
Price / Sales	N/A	73.29	613.48	92.60
Price / Cash	1.63	33.14	77.82	52.26
Price / Book	1.97	6.04	12.89	6.14
Net Income	$4.14M	$150.03M	$3.47B	$349.01M
7 Day Performance	-1.22%	-1.30%	0.61%	-0.27%
1 Month Performance	-19.25%	1.29%	5.73%	0.68%
1 Year Performance	N/A	9.89%	25.37%	14.84%

Check-Cap Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MBAI Check-Cap	0.4986 of 5 stars	$6.50 +0.3%	N/A	N/A	$8.91M	N/A	N/A	80
TELA TELA Bio	3.1574 of 5 stars	$0.75 -4.9%	$2.20 +192.4%	-52.7%	$33.78M	$79.91M	N/A	120
ARAY Accuray	2.6947 of 5 stars	$0.26 +2.1%	$2.00 +669.2%	-81.8%	$31.05M	$401.95M	N/A	1,040	Analyst Downgrade
QTEX Inspira Technologies OXY B.H.N.	0.1884 of 5 stars	$0.82 +2.2%	N/A	N/A	$29.35M	$290K	N/A	20	News Coverage Gap Up
IINN Inspira Technologies OXY B.H.N.	0.0108 of 5 stars	$0.80 -3.5%	N/A	-30.2%	$28.71M	$289K	N/A	20	Gap Up High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MBAI) was last updated on 9/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Check-Cap (MBAI) Competitors

MBAI vs. TELA, ARAY, QTEX, IINN, and MODD

How does Check-Cap compare to TELA Bio?

Summary

How does Check-Cap compare to Accuray?

Summary

How does Check-Cap compare to Inspira Technologies OXY B.H.N.?

Summary

How does Check-Cap compare to Inspira Technologies OXY B.H.N.?

Summary

How does Check-Cap compare to Modular Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MBAI vs. The Competition

Check-Cap Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Check-Cap (MBAI) Competitors

MBAI vs. TELA, ARAY, QTEX, IINN, and MODD

How does Check-Cap compare to TELA Bio?

Which has more risk & volatility, TELA or MBAI?

Do institutionals and insiders believe in TELA or MBAI?

Is TELA or MBAI more profitable?

Do analysts rate TELA or MBAI?

Which has higher earnings and valuation, TELA or MBAI?

Does the media favor TELA or MBAI?

Summary

How does Check-Cap compare to Accuray?

Do analysts rate ARAY or MBAI?

Is ARAY or MBAI more profitable?

Which has more risk and volatility, ARAY or MBAI?

Does the media refer more to ARAY or MBAI?

Do institutionals & insiders hold more shares of ARAY or MBAI?

Which has preferable valuation & earnings, ARAY or MBAI?

Summary

How does Check-Cap compare to Inspira Technologies OXY B.H.N.?

Which has more risk and volatility, QTEX or MBAI?

Which has stronger earnings & valuation, QTEX or MBAI?

Is QTEX or MBAI more profitable?

Does the media favor QTEX or MBAI?

Do institutionals and insiders hold more shares of QTEX or MBAI?

Do analysts prefer QTEX or MBAI?

Summary

How does Check-Cap compare to Inspira Technologies OXY B.H.N.?

Is MBAI or IINN more profitable?

Does the media prefer MBAI or IINN?

Which has preferable valuation & earnings, MBAI or IINN?

Do analysts prefer MBAI or IINN?

Do institutionals & insiders have more ownership in MBAI or IINN?

Which has more volatility and risk, MBAI or IINN?

Summary

How does Check-Cap compare to Modular Medical?

Do analysts prefer MBAI or MODD?

Which has more volatility & risk, MBAI or MODD?

Do institutionals and insiders believe in MBAI or MODD?

Which has preferable valuation & earnings, MBAI or MODD?

Is MBAI or MODD more profitable?

Does the media refer more to MBAI or MODD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MBAI vs. The Competition

Check-Cap Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools